CDMO company Cambrex completed the second phase of an expansion at its Snapdragon Chemistry API production facility in Waltham, Massachusetts.The project added 51,000 square feet to the facility’s footprint, the company said in a May 16 press release. Among the new features at the plant are process R&D labs with 100-liter and 60-liter glass-lined steel reactors plus a 10-liter plug flow reactor, the company said.
Cambrex didn't reveal its total investment in the project. The company expects the new suites to be operating in June.
"The capabilities and capacity added in Waltham are designed to support the industry's most complex chemical development needs, consistent with Snapdragon's expertise and history," Tom Loewald, Cambrex chief executive, said in the release.
Cambrex acquired Snapdragon for an undisclosed sum in November as part of its strategy to expand API offerings. With the deal, Cambrex picked up two Snapdragon facilities in Waltham.
Prior to the Cambrex purchase, Snapdragon had been courted by Chinese CDMO Asymchem. However, that deal fell apart in September when both sides were unable to meet terms to satisfy the Treasury Department’s Committee on Foreign Investment in the U.S.

Reference: https://deal.town/questex/051823-teva-ceo-reveals-long-term-strategy-az-fibrogens-evrenzo-finally-chalks-up-a-win-F3ZAHNRP9